Skip to main content

Table 3 Responses to the EQ-5D and SF-12 by clinical condition.

From: Assessing the construct validity of the Italian version of the EQ-5D: preliminary results from a cross-sectional study in North Italy

Clinical Condition (n) OR of reporting an impairment Beta coefficient
  Mobility α Self-care α Usual activities α Pain/discomfort α Anxiety/depression α EQ-5D index α-UK EQ-5D vas α EQ-VAS score
Diabetes (59) 4.8 (2.7–8.7) 4.8 (2.4–9.5) 3.5 (1.9–6.2) 2.8 (1.5–5.2) 1.7 (1.0–3.0) -0.11* -0.19* -0.13*
Without (1423)         
Visual impairment (159) 7.0 (4.7–10.4) 7.9 (4.8–12.9) 7.4 (5.0–10.9) 4.0 (2.6–6.1) 2.6 (1.8–3.7) -0.32* -0.34* -0.34*
Without (1295)         
Hearing impairment (204) 5.8 (4.0–8.3) 5.3 (3.3–8.4) 4.7 (3.3–6.7) 3.3 (2.3–4.6) 2.1 (1.5–2.9) -0.24* -0.24* -0.25*
Without (1275)         
Anxiety (233) 2.5 (1.7–3.6) 3.2 (2.0–5.2) 2.9 (2.1–4.2) 2.0 (1.5–2.7) 17.1 (10.9–26.9) -0.31* -0.26* -0.29*
Without (1234)         
Head ache at least once a week (351) 1.7 (1.2–2.3) 1.6 (1.0–2.6) 1.9 (1.4–2.7) 4.0 (3.0–5.4) 2.4 (1.8–3.1) -0.24* -0.13* -0.20*
Without (1118)         
Hypertension (277) 4.0 (2.8–5.8) 4.6 (2.7–7.7) 2.9 (2.0–4.2) 1.8 (1.3–2.5) 1.5 (1.1–2.0) -0.19* -0.29* -0.20*
Without (875)         
Heart failure (35) 22.0 (8.6–56.0) 21.0 (9.4–46.3) 14.1 (6.0–33.2) 4.3 (1.6–11.5) 2.2 (0.9–4.9) -0.25* -0.23* -0.25*
Without (1125)         
Angina (21) 3.3 (1.2–8.6) 4.5 (1.5–13.4) 5.3 (2.1–13.6) 1.9 (0.7–5.3) 3.1 (1.1–8.3) -0.09** -0.11** -0.10**
Without (1140)         
COPD (84) 4.4 (2.6–7.5) 3.0 (1.5–6.0) 4.8 (2.8–8.2) 3.3 (1.9–5.8) 1.2 (0.7–2.0) -0.14* -0.21* -0.19*
Without (1075)         
Asthma (39) 1.3 (0.5–3.0) 2.4 (0.9–6.5) 3.1 (1.5–6.5) 1.2 (0.6–2.5) 1.6 (0.8–3.2) -0.06** -0.07** -0.07**
Without (1140)         
Back pain (327) 4.6 (3.2–6.7) 3.0 (1.8–5.1) 2.9 (2.1–4.2) 3.6 (2.7–4.9) 1.5 (1.1–1.9) -0.25* -0.28* -0.25*
Without (814)         
Stomach ulcer (35) 1.9 (0.8–4.3) 2.0 (0.7–5.8) 2.9 (1.4–6.3) 3.6 (1.5–8.6) 1.6 (0.8–3.3) -0.12* -0.08** -0.10*
Without (1120)         
Arthritis (314) 7.8 (5.3–11.6) 3.7 (2.2–6.2) 4.1 (2.8–5.8) 4.5 (3.3–6.3) 1.5 (1.1–2.0) -0.3* -0.35* -0.32*
Without (833)         
Obesity (BMI >30) (163) 3.5 (2.3–5.2) 1.9 (1.1–3.4) 2.2 (1.4–3.3) 1.7 (1.2–2.4) 1.3 (0.9–1.8) -0.08** -0.12* -0.11*
Without (1283)         
  1. αAdjusted for age and gender where * p <0.001 and ** p <0.05
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us